Market Currents
Microcap bioresearch firm Adventrx Pharmaceuticals (ANX -1.1%) is lower today after the FDA says...
-
Monday, October 3, 2011, 12:26 PM ETMicrocap bioresearch firm Adventrx Pharmaceuticals (ANX -1.1%) is lower today after the FDA says the company will need to repeat a study of its lung-cancer treatment Exelbine because it can't verify the authenticity of certain drugs in the previous trial. The shares have been pummeled this year, down nearly 78% since mid-July.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
